Apellis Pharmaceuticals, Inc. (APLS)
40.63
+0.22
(+0.54%)
USD |
NASDAQ |
Apr 06, 16:00
40.60
-0.03
(-0.07%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap : 5.222B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 24.57B |
| Eli Lilly & Co. | 820.48B |
| Agios Pharmaceuticals, Inc. | 2.015B |
| Scholar Rock Holding Corp. | 5.470B |
| BridgeBio Pharma, Inc. | 13.85B |
Market Cap Related Metrics
| PE Ratio | 330.78 |
| PS Ratio | 5.171 |
| Price to Book Value | 14.11 |
| Price to Free Cash Flow | 115.30 |
| Price | 40.63 |
| Earnings Yield | 0.30% |
| Operating PE Ratio | 93.64 |
| Normalized PE Ratio | 330.78 |